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esponsibility of Xi'aAbstract Lipopeptides are currently re-emerging as an interesting subgroup in the peptide research ﬁeld,
having historical applications as antibacterial and antifungal agents and new potential applications as
antiviral, antitumor, immune-modulating and cell-penetrating compounds. However, due to their speciﬁc
structure, chromatographic analysis often requires special buffer systems or the use of triﬂuoroacetic acid,
limiting mass spectrometry detection. Therefore, we used a traditional aqueous/acetonitrile based gradient
system, containing 0.1% (m/v) formic acid, to separate four pharmaceutically relevant lipopeptides
(polymyxin B1, caspofungin, daptomycin and gramicidin A1), which were selected based upon
hierarchical cluster analysis (HCA) and principal component analysis (PCA).
In total, the performance of four different C18 columns, including one UPLC column, were evaluated
using two parallel approaches. First, a Derringer desirability function was used, whereby six single and
multiple chromatographic response values were rescaled into one overall D-value per column. Using this
approach, the YMC Pack Pro C18 column was ranked as the best column for general MS-compatible
lipopeptide separation. Secondly, the kinetic plot approach was used to compare the different columns at
different ﬂow rate ranges. As the optimal kinetic column performance is obtained at its maximal pressure,
the length elongation factor λ (Pmax/Pexp) was used to transform the obtained experimental data (retention
times and peak capacities) and construct kinetic performance limit (KPL) curves, allowing a direct visual
and unbiased comparison of the selected columns, whereby the YMC Triart C18 UPLC and ACE C18sity. Production and hosting by Elsevier B.V. All rights reserved.
1
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M. D’Hondt et al.174columns performed as best. Finally, differences in column performance and the (dis)advantages of both
approaches are discussed.
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♯ Compound Formula Mr
a Ref.
1 Amphomycin C58H91N13O20 1290.42 [2]
2 Anidulafungin C58H73N7O17 1140.24 [2]
3 Arthrofactin C64H111N11O20 1354.63 [5]
4 Caspofungin C52H88N10O15 1093.31 [2]
5 Cilofungin C49H71N7O17 1030.12 [6]
6 Colistin A C53H100N16O13 1169.46 [2]
7 Colistin B C52H98N16O13 1155.43 [2]
8 Dalbavancin C88H100Cl2N10O28 1816.69 [2]
9 Daptomycin C72H101N17O26 1620.67 [2]
10 Echinocandin B C52H81N7O16 1060.24 [2]
11 Gramicidin A1 C99H140N20O17 1882.29 [7]
12 Iturin A2 C48H74N12O14 1043.17 [8]
13 Micafungin C56H71N9O23S 1270.27 [2]
14 MX-2401 C67H101N15O22 1468.61 [2]
15 P3CSS C60H113N3O11S 1084.62 [9]
16 Plipastatin C72H110N12O20 1463.71 [10]
17 Polymyxin B1 C56H98N16O13 1203.48 [2]
18 Ramoplanin A2 C119H154N21O40 2554.07 [11]
19 Surfactin C53H93N7O13 1036.34 [10]
20 Syringomycin E C53H85ClN14O17 1225.78 [12]
21 Teicoplanin A2-2 C88H97ClN12O33 1879.66 [13]
22 Telavancin C80H106Cl2N11O27P 1755.64 [2]
Bold: selected lipopeptides based upon PCA and HCA.
aCalculated values using MarvinSketch software (version 5.4.1.1,
ChemAxon Ltd.).1. Introduction
As can be derived from the name, lipopeptides differ from ordinary
peptides in the connection of an acyl chain to a linear or cyclic (oligo)
peptide structure, resulting in amphiphilic properties [1]. Natural
lipopeptides originate mostly from a bacterial or fungal origin, in
which Pseudomonas and Bacillus species have been studied exten-
sively. Certain lipopeptide compounds exert an antibacterial function
through pore formation in membranes, resulting in bacterial death.
Currently, they are used as a last line of defense in treatment of
infections caused by multidrug-resistant organisms. Other lipopep-
tides block the 1–3-β-glucan synthase enzyme, which results in a
fungicidal activity due to loss of cell wall integrity [2–13]. Moreover,
some lipopeptides have known antiviral and antitumor, as well as
immune-modulating properties through Toll-like receptors [14–17].
Currently, lipopeptides are also under investigation to be applied as
cell-penetrating peptides (CPP). The addition of an acyl chain to cell-
penetrating peptides generally enhance the penetration efﬁciency of
these components, allowing transport of short oligonucleotides
(DNA, RNA), plasmid DNA and proteins into the cell, rendering
them a promising class of non-viral delivery vectors [18–20].
Lipopeptides are also important chemical compounds in the quorum
sensing mechanisms between bacteria, playing a role in i.a., bioﬁlm
formation [21–24].
Lipopeptides are thus becoming an increasingly important
subgroup of peptides, attracting more and more pharmaceutical
and biomedical attention. However, due to their speciﬁc structure,
chromatographic analysis often requires the use of special buffer
systems, e.g., sodium sulfate [25–28] or triﬂuoroacetic acid
[29–32]. These systems are not directly compatible with mass
spectrometry or can cause quantiﬁcation problems due to ion
suppression [33]. Therefore, the goal of this study was to deﬁne
the best LC–MS compatible system for general lipopeptide
analysis, using a formic acid containing water/acetonitrile based
gradient. Samples possibly containing new, undiscovered, bioac-
tive lipopeptides can be screened by this new (U)HPLC–MS
method. Therefore, the main focus point of this article was the
separation of different lipopeptide classes, representing the major-
ity of the lipopeptide chemical space. To achieve this, we have
ﬁrst selected a number of model lipopeptides from a list of 22
pharmaceutically relevant lipopeptides (Table 1), using their
chemical descriptors and applying clustering techniques (HCA
and PCA).
The four LC columns were selected based on their pharmacopoeial
and general use in lipopeptide analysis. Column comparison was
performed using two parallel approaches. First, using similar
chromatographic conditions, the performance was evaluated and
ranked using a Derringer desirability function, combining six
individual chromatographic responses, each given the same weight,
i.e., asymmetry factor, limit of detection (LOD), time-corrected
resolution product, separation factor, peak capacity and chromato-
graphic response factor [34]. Secondly, the kinetic plot approach is
based on the principle that the kinetic optimum of a chromatographic
system or column is achieved when a preset desired efﬁciency or
peak capacity is reached in the shortest possible time frame oralternatively, when a maximum efﬁciency is reached during a preset
time frame. Therefore, a plot of the analysis time vs. the plate number
(isocratic) or peak capacity (gradient) provides the most direct way to
compare the performance of chromatographic systems with different
physicochemical properties. As this kinetic optimum is always
obtained when the chromatographic system is operated at its maximal
pressure, the different columns are therefore compared on an
unbiased basis, i.e., preventing that one column is tested under less
than optimal conditions [35–40]. Finally, both approaches are com-
pared.2. Materials and methods
2.1. Materials
Polymyxin B sulfate (Ph. Eur. quality [27]) was bought at Genaxxon
BioScience (Ulm, Germany). Gramicidin A (490% purity) and formic
acid (MS grade498%) were obtained from Sigma Aldrich (Bornem,
Belgium). Cubicins (containing 94.6% (w/w) daptomycin—Novartis)
and Cancidass (containing 41.7% (w/w) caspofungin—MSD) were
purchased from Care4Pharma (Schiphol, The Netherlands). Acetoni-
trile (LC–MS grade) was purchased from Fisher Scientiﬁc (Aalst,
Belgium). Water was puriﬁed using an Arium 611 puriﬁcation system
(Sartorius, Gottingen, Germany) yielding Z18.2 MΩ cm quality
Lipopeptide LC 175water. YMC Pack Pro C18, YMC Triart C18 HPLC, ACE C18
(all 250 mm 4.6 mm I.D.; 5 mm particle size) and YMC Triart C18
UPLC (100 mm 2.0 mm I.D.; 1.9 mm particle size) columns were
obtained from Achrom (Machelen, Belgium).
2.2. Lipopeptide clustering
The molecular structures of 22 pharmaceutically relevant lipopep-
tides in isomeric SMILES format [41], were imported into
MarvinSketch (version 5.4.1.1, ChemAxon Ltd.), thus obtaining
a two-dimensional peptide model. The selection was based upon
(i) clinical application as antibacterial agent (e.g., polymyxin B
sulfate), antifungal agent (e.g., anidulafungin) or adjuvant (e.g.,
P3CSS) and (ii) prior use in biomedical research, i.e., new potential
APIs (e.g., MX-2401). As some lipopeptides consisted of mixtures
of closely related compounds (e.g., polymyxin B1, B1-I, B2 and
B3), the structures of the main compound (e.g., polymyxin B1)
were considered in this study. Gramicidin A1, although strictly
speaking not a lipopeptide, was also included in this set of 22,
based upon its similar antibacterial working mechanism (i.e., pore
formation in bacterial cell wall) and its deviating structure as it
does not contain the typical conjugated acyl chain present in the
other selected lipopeptides, but rather a series of hydrophobic
amino residues (alanine, valine and leucine). Structural informa-
tion of the 22 lipopeptides used in this clustering is given in
Supplementary Data.
Three-dimensional structure optimization was performed using
HyperChem 8.0 (Hypercube, Gainesville, FL, USA) software. The
molecular mechanics force ﬁeld method using the Polak–Ribière
conjugate gradient algorithm, with a root mean square (RMS) of
0.1 kcal/(Å mol) as termination condition, was used. Using the
3-D optimized lipopeptide structures, 3224 descriptors were
calculated using Dragon (version 5.5, Talete), 5 descriptors were
calculated using MarvinSketch software (pI and Log D at pH 2.0,
5.5, 7.4 and 10.0) and 7 descriptors were calculated using the
HyperChem software [42]: the solvent accessible Surface Area
(i, ii) was computed using both the fast approximate method and a
more accurate grid algorithm. The lipopeptide Volume (iii)
calculation also employed this grid algorithm. The calculation of
the Hydration Energy (iv), which determines the stability of the
molecular conformation, was based on the exposed surface area.
Log P (v) and Refractivity (vi) values were estimated by the
Ghose, Pritchett and Crippen approach, whereby each atom
contributes to the overall hydrophobicity and refractivity, respec-
tively. Finally, Polarizability (vii) was calculated based upon
different increments associated with the different atom types. In
total, 3236 descriptors were obtained for each lipopeptide.
Elimination of constant descriptors, i.e., identical value for all
lipopeptides, reduced the number of descriptors to 1464. Each
descriptor data set was then transformed into a N (0,1) distribution
using z-score normalization
z¼ xX
SD
where, x is the individual value of a data point, X is the mean and
SD is the standard deviation of the descriptor data set.
Lipopeptide clustering was performed using HCA analysis
with SPSS software (SPSS 19, IBM) and PCA with SIMCA-
Pþ software (version 12.0, Umetrics). The HCA is used for
pattern recognition based on similarities between objects
according to the Euclidean distance and the result is visualized
in a dendrogram. Starting from the individual components,branches are built up to form clusters. The length of the
branches are inversely related to their similarity, thus short
branches mean high similarity. PCA is a tool for the inter-
pretation of large data tables and visualization of systematic
trends. In this approach the multidimensional space, charac-
terized by the 1464 descriptor variables, is reduced to principal
components (PC), which are linear combinations of the
original variables, whereby the ﬁrst PC withholds the most
variability in the data set. Based on commercial availability, a
lipopeptide representative for each of the formed clusters was
used for further column comparison.
2.3. Column selection
Four different stationary phases were evaluated for lipopeptide
separation. The YMC Pack Pro C18 column (Vc: 2.125 mL) was
selected based on the work of Orwa et al. [26], where this column
showed the best chromatographic separation of the different
polymyxin B sulfate constituents. The second and third columns,
i.e., the YMC Triart C18, have comparable hydrophobicity k′
(amylbenzene) value as the YMC Pack Pro C18 column (both
approximately 7.0), but have a 20% lower hydrogen bonding
capacity α (caffeine/benzene) due to a multi-stage endcapping
procedure of the residual silanol groups (the YMC Pack Pro C18:
0.105 vs. 0.085 for the YMC Triart C18 chemistry) [43]. This
stationary phase was obtained both in HPLC (Vc: 2.082 mL) and
UPLC (Vc: 0.438 mL) compatible format, of which the latter, due
to lower particle size (1.9 mm), has the additional beneﬁt of its
ultra-fast analysis time. The last column, i.e., ACE C18 (Vc:
1.968 mL) was selected based on a column comparison which
indicated better peak shape and column efﬁciency when compared
to the YMC Pack Pro C18 column for basic compounds, while the
hydrophobicity and selectivity are very close to the YMC Pack Pro
C18 stationary phase [44].
2.4. Chromatography
The UPLC apparatus consisted of a Waters Acquity H UPLC
Class Quaternary Solvent Manager, a Waters Acquity Sample
Manager, combined with a Flow Through Needle, and a Waters
Acquity Ultra Performance LC PDA (500 nL–10 mm path length
analytical ﬂow cell) detector, with Empower 2 software for data
acquisition. Mobile phases consisted of 0.1% (m/v) formic acid in
water (A) and 0.1% (m/v) formic acid in acetonitrile (B). A general
linear gradient was implemented running from 10% B to 90% B in
25 column volumes (Vc) followed by returning to the initial
conditions and re-equilibration. A lipopeptide mixture sample
containing 0.1 mg/mL polymyxin B sulfate, gramicidin A, dapto-
mycin and 1.0 mg/mL caspofungin was prepared in H2O/ACN
(50:50, v/v) containing 0.1% formic acid. Higher concentrations
exceeded the solubility, yielding a turbid solution. Column
temperature was set at 40 1C (75 1C) and sample compartment
at 5 1C (73 1C). The injection volumes for the HPLC and UPLC
column analysis were set at 10 mL and 2 mL, respectively. UV-
detection was performed at 215 nm, using a sampling rate of
20 Hz combined with a detector time constant of 0.1 s. The ﬂow
rates for the Derringer comparison were set at 1.0 and 0.5 mL/min
for the HPLC and the UPLC columns, respectively. The ﬂow rate
settings used in the kinetic plot approach are discussed in detail
in Section 2.6. As mentioned in Section 2.2, only the major
constituent of the individual lipopeptide (i.e., polymyxin B1 in the
M. D’Hondt et al.176polymyxin B sulfate and gramicidin A1 in gramicidin A) was
considered, as the main objective was to evaluate the separation
between structurally different lipopeptides, rather than between the
closely related ones.
2.5. Derringer comparison—chromatographic response factors
The lipopeptide chromatographic characteristics were divided into
six different response factors, containing both single and multiple
responses, and are presented in Table 2 [27,45,46]. As four
lipopeptides were analyzed on each column, 3–4 separate values
for certain single responses, i.e., separation factor (S) and asym-
metry factor (As), were obtained per column. These separate values
of these single responses, as well as the multiple responses, were re-
expressed as a dimensionless desirability scale (d) using two linear
desirability functions, depending on whether the desired chromato-
graphic response was to be minimized, e.g., LOD, or maximized, e.
g., peak capacity. The geometrical mean of the aforementioned
separate d-values of the single responses was calculated to obtain
one average d-value for the single response per column. Finally, the
geometrical mean of the six d-values was calculated in order to
assess the overall performance (D-value) of each column [34,46],
thereby appointing equal weights to each of the six response factors.
Minimized : dðYÞ ¼ 1:1YmaxYi
1:1Ymax 0:9Ymin
Maximized : dðYÞ ¼ Yi0:9Ymin
1:1Ymax 0:9Ymin
Desirability function : D¼ ∏
x
i ¼ 1
di
 1=x
In which d is the desirability value, D is the geometric mean of
the desirability values, Yi are the experimental response value and
Ymin and Ymax are the minimal and maximum values within the
experimental data set.Table 2 Selected chromatographic response factors and formulas.
# Response factor
1 Asymmetry factor (As)
2 Limit of detection (LOD) (ng)
3 Time-corrected resolution product (Rs corr)
4 Separation factor (S)
5 Peak capacity (np)
6 Chromatographic response function (CRF)
w0.05: peak width at one-twentieth of the peak height.
wh: width of the peak at half-height.
d: distance between the perpendicular dropped from the peak maximum an
H: height of the peak.
h: range of the noise.
tR: retention time of the peak corresponding to the component.
t0: column dead time.
RTmax: t0-corrected tR of the last peak, expressed as column volume.
tg: deﬁned gradient run time expressed in column volume.
a: 1.
b: 1.
aNumber of responses obtained per column.2.6. Kinetic plots
Kinetic performance limit (KPL)-curves were constructed for each
column by performing the experiments described in Section 2.4 at
different ﬂow rates, whereby the total gradient time was adjusted
accordingly, i.e., ﬁxed at 25 Vc, in order to conserve equal gradient
steepness. For each individual column experiment at a given ﬂow
rate, the corresponding peak capacity np;exp was calculated
(Table 2). These experimental peak capacities np;exp, as well as
the retention times (TR) of the last eluting lipopeptide, i.e.,
gramicidin, were subsequently converted into KPL-data points,
(i.e., np;KPL and TR;KPL) using the length elongation factor λ:
λ¼ Pmax
Pexp
where Pmax is the maximum allowed column or system pressure
and Pexp is the maximum pressure achieved during the chromato-
graphic analyses.
np;KPL ¼ 1þ
ﬃﬃ
λ
p
 ðnp 1Þ
TR;KPL ¼ λTR
To determine the ﬂow rate range to be used within the kinetic plot
experiments, the highest ﬂow rates, resulting in a still acceptable Pexp
column pressure were determined for the four selected (U)HPCL
columns. The lowest ﬂow rates were determined in reference to the
ﬁxed ﬂow rates used during the Derringer column comparison. Thus,
the ﬂow rate ranges used for the kinetic plot evaluation of the HPLC
and UPLC columns were 0.60–1.40 mL/min and 0.20–0.80 mL/min,
respectively, with 7 different rates per column. Subsequently, each of
the 7 obtained data points per column was plotted (TR;KPL in function
of np;KPL) to obtain the KPL-curve [35–40].Formula ♯a
As ¼ w0:052d 4
S
N ¼ 2Hh ¼ 3 4
Rs ¼ 1:18ðtR2 tR1Þwh1þ wh2
∏Rs corr ¼ ∏RsTRmax
1
S ¼ tR2 t0tR1 t0 3
np ¼ 1þ tg1=nð∑n1whÞ 1
CRF ¼ a∑n1i ¼ 1Rs i; iþ1 þ bðtg RTmaxÞ 1
d the leading edge of the peak at one-twentieth of the peak height.
Fig. 1 Dendrogram obtained from hierarchical cluster analysis of 22 lipopeptides.
Fig. 2 Principal component analysis score plot (PC1–PC2) for the 22 lipopeptides.
Lipopeptide LC 1773. Results and discussion
3.1. Lipopeptide clustering
The resulting dendrogram of the HCA and the results of the PCA,
visualized by means of score plots, are shown in Figs. 1 and 2. Theﬁrst four PCs explained approximately 80% of the structural
variability of the 22 selected lipopeptides.
Based on the PCA result (Fig. 2), we can see that peptides 15, 11
and 18 (clusters 6, 7 and 8), and to a lesser extent, components 22, 8
and 21 (‘violet’ cluster 5), are very dissimilar to all other components
which are classiﬁed into three major clusters (red, green and blue
M. D’Hondt et al.178clusters, 1–3) and a fourth cluster containing micafungin (13). This can
also be observed in the HCA dendrogram (Fig. 1, similar color legend).
The major lipopeptide cluster, containing 72% of the originally selected
lipopeptides, includes compounds adhering to the most strict lipopep-
tide deﬁnition, i.e., direct connection of an acyl chain to a linear or
cyclic (oligo)peptide structure. As previously mentioned, this major
cluster can be divided into four sub-clusters, thus classifying the
original 22 components into 8 clusters. The other, structurally deviating
lipopeptides still contain the connection of an acyl chain to a linear or
cyclic (oligo)peptide structure, but also include sugar residues (ramo-
planin—peptide 18), multiple lipid chains (P3CSS—peptide 15) or
alternative linkage between acyl chain and peptide structure (cluster 5,
peptides 8, 21 and 22) in their structures (Supplementary Data).
Gramicidin (peptide 11) does not contain the typical conjugated acyl
chain present in the other selected lipopeptides, but rather a series of
hydrophobic amino residues (alanine, valine and leucine).
Based on commercial availability, lipopeptide representatives,
i.e., polymyxin B1 (17, belonging to the red cluster 1), caspofungin
(4, green cluster 2), daptomycin (9, blue cluster 3) and gramicidin
A1 (11, cluster 6) were selected, thus representing the major
lipopeptide cluster as well as one structurally different cluster.3.2. Chromatographic response factors—Derringer comparison
The chromatographic responses, together with their calculated d-values
and overall D-value, are presented in Table 3. The chromatograms
obtained using the four different columns are depicted in Fig. 3.
The average lipopeptide asymmetry factor, calculated using the
four individual As of the lipopeptides, showed large variability
(average 81% RSD) on each of the selected columns, which can be
explained by the fact that the four lipopeptides were selected based
on their structural diversity, resulting in different interactions with
the stationary phase. The best As results, i.e., closest to 1 for the 4
lipopeptides, were obtained with the YMC Pack Pro C18 column
(average As: 1.16, 45% RSD), suggesting a more uniform lipopep-
tide column interaction. Alternatively, the average asymmetry factor
of the individual lipopeptides on the four different columns showed
a smaller variability (average 38% RSD), which can be explained by
the different endcapping procedures/efﬁciencies leading to differentTable 3 Chromatographic response values, calculated desir-
ability values (d) and overall desirability values (D).
Parameter ACE
C18
YMC Pack
Pro C18
YMC Triart
C18 HPLC
YMC Triart
C18 UPLC
As 3.783 1.160 1.912 2.343
d 0.529 0.658 0.262 0.247
LODa 14.605 56.822 29.381 3.064
d 0.725 0.239 0.248 0.991
Rs corr 250.96 1350.88 153.10 69.91
d 0.132 0.905 0.063 0.005
S 1.335 2.188 1.805 1.574
d 0.428 0.807 0.469 0.287
np 180.400 172.931 142.927 113.523
d 0.813 0.735 0.423 0.118
CRF 70.182 97.984 58.519 47.853
d 0.419 0.849 0.239 0.074
D 0.441 0.644 0.241 0.120
Bold: best chromatographic response/highest d or D value.
aAbsolute mass on column (ng).amounts of peak tailing. However, Grubbs outlier testing (α: 0.05)
showed no outliers in the individual lipopeptide asymmetry factors,
indicating that the individual lipopeptides interacted in a similar way
with all of the four selected stationary phases.
The LOD is the smallest amount of substance that is accurately
detectable, having a S/N ratio of 3. Both the signal or peak height,
which can be correlated to the ‘sharpness’ of the peak, and the
amount of noise determine the LOD value. The average noise value
obtained with the four columns is calculated to be 2.121 104 AU
(22.03% RSD). On the other hand, the peak heights of the individual
lipopeptides were seen to differ between the selected columns
(Fig. 3). This peak height is directly proportionate to the detectors
ability of detecting the solute concentration at the maximum of the
peak (Cmax). As all analyses were performed using the same
chromatographic system (incl. tubings, injector and detector), any
observed peak broadening, resulting in decrease in peak height, can
be attributed to the analytical column. Moreover, peak areas of the
four lipopeptides analyzed on the three HPLC columns were found to
be similar (%RSD ranging from 1.22 to 8.11).
The relationship between the Cmax and the column parameters is
summarized in following formula [47]:
Cmax ¼
4
εtπ
ﬃﬃﬃﬃﬃ
2π
p ð1þ jAs1jÞ

ﬃﬃﬃﬃ
N
p
Ld2c
 V0C0ð1þ k0 Þ
Derivation of the formula is thoroughly discussed in
Supplementary Data. In this formula, the ﬁrst term includes the
column porosities (εt), which were found to be similar throughout
the four columns. This term also corrects the Gaussian peak proﬁle
for the any peak asymmetries, both fronting and tailing. As the
average asymmetry factors ranged from 1.16 to 3.78, this will have
a signiﬁcant inﬂuence on the LOD (Table 3).
The second term incorporates the column efﬁciency (N) and the
column dimensions, i.e., length (L) and diameter (dc). On its own, N
is inﬂuenced by column length (L) and particle size (dp) (N  L=dpÞ.
When comparing the HPLC and UPLC columns, L is reduced from
250 to 100 mm, and the dp is reduced from 5 mm to 1.9 mm, resulting
in a near constant L=dp ratio of 50,000 for both column dimensions
(i.e., 250; 000 mm=5 mm ðHPLCÞ  100; 000 mm=1:9 mm ðUPLCÞ).
However, the reduction in column dimensions, i.e., L (250–100 mm)
and dc (4.6–2.0 mm), will increase the Cmax result and thus the peak
height.
The third and ﬁnal term, links the Cmax to the absolute mass
loaded onto the column, i.e., injection volume (v0Þ and concentra-
tion (c0Þ, as well as to the retention characteristics (k′). As c0 is
constant, the absolute mass loaded onto the HPLC column is 5
times higher than the mass injected onto the UPLC column (10 vs.
2 mL v0). However, as the LOD is expressed as absolute mass, the
calculations already accounted for this difference in absolute mass
loaded onto the UPLC column (see Supplementary Data). It also
takes into account the capacity factor, which do not differ
signiﬁcantly throughout the four columns (% RSD of the
lipopeptide k′ values on the four different columns range from
21% to 50%).
When summarizing these different LOD inﬂuences, i.e., reduction
of column length, column diameter and peak asymmetry factor, the
YMC Triart C18 UPLC peak height will be approximately 11 times
higher as the peak height obtained using the YMC Triart C18 HPLC
column when identical quantities (mass) are injected. Indeed, the
LOD results for the YMC Triart C18 HPLC and UPLC columns,
i.e., 29 and 3 ng respectively, demonstrate this underlying relation-
ship, as their LOD values differ by approximately a factor 10.
Fig. 3 Typical chromatograms obtained during the Derringer column comparison. The X-axis was ﬁxed at 25 column volumes. Peaks indicated
by arrow are the selected lipopeptides (left to right: polymyxin B1 (17), caspofungin (4), daptomycin (9) and gramicidin A1 (11)); peaks indicated
by braces are considered blank peaks.
Lipopeptide LC 179The high LOD value observed when using the YMC Pack Pro
C18 column is caused by an unretained fraction of the injected
polymyxin B1, causing a smaller retained polymyxin B1 peak (i.e.,
smaller S value), leading to a relative high LOD value for
polymyxin, which in turn leads to a higher average LOD value
for the four lipopeptides, and smaller LOD d-value for the YMC
Pack Pro C18 column. The presence of polymyxin B1 compounds
in the unretained peak was veriﬁed using mass spectrometry (MS1
and MS2). Different factors (polymyxin B1 concentration, column
temperature, gradient composition, column batch and sample
solvent strength) were varied to investigate their inﬂuence on this
peculiar polymyxin B1 retention pattern. The main cause of this
observed dual retention, which is inﬂuenced by a variety of
parameters, is the strength of the sample solvent in relationship
to the starting strength of the applied gradient. As the sample,
dissolved in 50/50 H2O/ACN sample solvent, is injected onto the
column, two processes occur. (i) A plug containing the strong
sample solvent will move unretained through the column, and due
to its strong solvent strength above the critical value for
desorption, will cause the polymyxin B1 to remain in this plug,
desorbed from the stationary phase. (ii) While moving through the
column, there is a diffusion of polymyxin B1 from this plug into
the mobile phase. In this mobile phase, polymyxin B1 adsorbs to
the hydrophobic surface of the stationary phase, and remains
adsorbed until the concentration of acetonitrile in the gradient
reaches the critical value necessary to cause sudden desorption
from the stationary phase. The diffusion process of polymyxin B1
from the plug into the mobile phase, and from there adsorption to
the stationary phase, occurs continuously whilst the plug is
moving through the column. This polymyxin B1 diffusion into
the mobile phase occurs throughout the entire column length,
resulting in polymyxin B1 being retained throughout the entirecolumn length, until the gradient at the right solvent strength
(i.e., critical value) sweeps away all desorbed polymyxin.
The resolution (Rs) takes into account three key factors:
(i) column efﬁciency (N), (ii) selectivity (α) and (iii) retention
factor (k). As mentioned above, N is determined by the column
length and particle size and as the L/dp ratios between the
evaluated HPLC and UPLC columns are constant, N will not
have an inﬂuence on the calculated Rs values. Selectivity (k1=k2)
and retention factors (ðTRT0Þ=T0) are closely related and are
determined by mobile phase composition, which was equal for all
columns evaluated, and by stationary phase. All columns are based
upon the same main separation principle, i.e., reversed-phase C18.
Therefore, no major selectivity differences, e.g., different elution
orders, were observed for the four lipopeptides. However, subtle
difference in stationary phase chemistries between the YMC Pack
Pro C18 and the other columns, also reﬂected in other chromato-
graphic parameters, resulted in higher selectivity values (e.g.,
YMC Pack Pro C18 vs. ACE C18: 1.38 vs. 1.18 for α
(daptomycin/caspofungin)) and subsequently higher Rs values.
The three individual Rs values, obtained for each column, are
recalculated into the time corrected resolution product (Rs corr),
which also takes the column dead volume corrected retention time
(expressed in column volume) of the last eluting lipopeptide in the
mixture, i.e., gramicidin A1, into account. This RTmax was similar
for all columns, i.e., 19.53 Vc (5.69% RSD). Calculation of the
separation factor S, only takes the column dead volume corrected
TR of the eluting components into account. The YMC Pack Pro
column performed the best. The average separation factors of the
other three columns showed high similarity, as was also noticed
for Rs corr parameter.
Peak capacity is determined by the total gradient run time and
by the individual peak widths at half maximum. The total gradient
M. D’Hondt et al.180run time (expressed as column volumes) is equal to 25 for all
columns. Therefore, the peak capacity, as calculated here, can be
correlated with the individual peak widths at half maximum. The
ACE C18 column performed best, closely followed by the YMC
Pack Pro C18 column. The chromatographic response factor takes
into calculation the three resolution results obtained for each
column and the retention time of the last eluting peak. The YMC
Pack Pro C18 column showed the highest CRF value, which is to
be expected as the column was also characterized by the highest
resolution values. The other three columns showed a comparable,
but statistically signiﬁcant, lower CRF value.
From the global desirability D-value, the YMC Pack Pro C18
column showed the best overall performance in the chromato-
graphic characteristics of pharmaceutically important lipopeptides.
However, a major drawback of this column was the observation of
an unretained fraction of polymyxin B1. The ACE C18 column
ranked as the second best column and the overall performance of
the YMC Triart C18 columns, both HPLC and UPLC, were found
to be rather similar (Table 3).3.3. Kinetic plots
The four constructed KPL-curves are depicted in Fig. 4. From the
extreme TR;KPL points, it can be derived that the YMC Triart C18
UPLC outperforms the three other columns in minimal analysis
time. Due to its nature, i.e., smaller void volume and particle size
together with higher maximal pressure limit, this UPLC column is
able to generate TR;KPL values below 20 min. This TR region is
inaccessible by the HPLC columns, as the maximal applicable
column pressure would be exceeded.
The highest column performance was obtained with the ACE
C18 and YMC Pack Pro C18 columns, i.e., np,KPL values of 288
and 284, respectively. As the only variable in the np calculation is
the peak-width at half-height, as Tg is constant, i.e., 25 Vc for each
column, one can expect that a UPLC column will generally result in
smaller, sharper peaks compared to an HPLC column, if the sample
amount is proportional among both. However, the mean peak width
at half-height (expressed in column volumes) using the UPLC
column is larger than those obtained with the HPLC columns (0.90
vs. 0.56 for ACE C18 and YMC Pack Pro C18). Even the
elongation factor λ, which is by far the largest for the UPLCFig. 4 Kinetic plot with YMC Triart C18 (UPLC);  ACE C18;
YMC Pack Pro C18; YMC Triart C18 (HPLC).column (4.0 vs. 2.5 for the ACE C18) cannot compensate for this
mean peak width difference, thus explaining this observation.
3.4. Comparison of the Derringer desirability vs. kinetic plot
approach
The KPL-curve depicted in Fig. 4 is based on only three variable
parameters, i.e., TR;KPL, np,KPL and λ and allows a fast and visual
interpretation of column performances. Alternatively, the Derringer
desirability function approach is based on using six chromatographic
responses, including the experimentally obtained np, which allows a
more exhaustive comparison of the selected columns. Moreover,
certain chromatographic responses can be emphasized in the
Derringer desirability approach by assigning certain weight factors.
However, the Derringer approach also increases the overall data
processing and interpretation time. Chromatography of the compo-
nents can be adjusted by ﬁne-tuning either the physical or the
chemical column properties. Regarding the comparison of chemical
properties and the interaction between the analytes and chromato-
graphic system, the Derringer desirability function outperforms the
kinetic plot method. For example, peak tailing is related to the
chemical properties of the stationary phase, thus providing initial
information of the column chemistry, which is lacking in the kinetic
plot method. Although the retention time of a compound on a given
column is also related to the column chemistry, the chemical
information which can be derived from the Derringer desirability
approach is superior to the kinetic plot approach.
As commonly known, the column performance can be depicted
in a so called the Van Deemter curve, where the column is
characterized by an optimum performance at a given ﬂow rate. The
Derringer desirability approach compares the columns at a preset,
quite often traditionally used ﬂow rates, which may not correspond
to the individual optimal ﬂow rates, thus introducing bias in the
overall D-value. By using the different ﬂow rates in the kinetic
plot approach and transforming the obtained data using the
elongation factor λ, each column is compared unbiased at its
kinetic optimum, i.e., at Pmax. However, the kinetic plot method
pushes the columns and the chromatographic system to their
pressure limits when the peak capacity is examined at the maximal
ﬂow rate, thus most likely shortening column and device life.
The Derringer desirability function maximizes or minimizes
individual data points into d-values, using the overall experimental
data set. This relative character does not allow easy introduction of
new columns into the comparison. However, the relative character
of the Derringer desirability function can be avoided by predeﬁn-
ing a set of maximal and minimal values for the chromatographic
responses. This is straightforward for certain responses, e.g., 1.0 as
optimal value for As, but other responses are ideally as high, e.g.,
np, or as low as possible, e.g., LOD. One must then consider the
speciﬁc purpose of the chromatographic method, e.g., the stability-
indicating method (low LOD) or high-throughput separations of
complex mixtures (high np) and deﬁne these optimal values to
meet these requirements upfront. Alternatively, the kinetic plot
approach is a stand-alone method, allowing incorporation of new,
untested columns in the plot as the depicted graphs can be
obtained independent from each other.4. Conclusions
A set of 22 different lipopeptides, mostly used for their antibacterial
or antifungal clinical characteristics in clinical applications, were
Lipopeptide LC 181classiﬁed into 8 major clusters using hierarchical cluster analysis
(HCA) and principal component analysis (PCA). Based on com-
mercial availability, representatives for 4 of the 8 clusters were
purchased, i.e., polymyxin B sulfate, caspofungin, daptomycin and
gramicidin A, representing the majority of the currently commer-
cially available lipopeptides.
The chromatographic separation, using a formic acid containing
water/acetonitrile gradient, of these four lipopeptide representa-
tives, was examined on four different (U)HPLC columns by two
different approaches. First, a Derringer desirability function was
employed using a combination of single (As, LOD, separation factor)
and multiple (time corrected resolution product, peak capacity and
chromatographic response factor) response parameters, wherein the
YMC Pack Pro C18 column was characterized by the highest
overall D-value, i.e., 0.644, but also showed an unretained
polymyxin B1 fraction. Alternatively, the kinetic plot approach, ﬁrst
transforms the retention times of the last eluting compound and
experimental peak capacities obtained at different ﬂow rates for each
column into (TR;KPL; np,KPL) using the elongation factor λ (Pmax/
Pexp). These obtained KPL data points are then plotted out. This
fairly straight forward approach appoints the YMC Triart C18
UPLC and ACE C18 as the most appropriate columns for the mass
spectrometry–compatible chromatographic analysis of lipopeptides.
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